BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 33802995)

  • 1. COVID-19 and Neurological Impairment: Hypothalamic Circuits and Beyond.
    Mussa BM; Srivastava A; Verberne AJM
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article.
    Taher T; Sheikh AB; Anwar F; Khosa F
    Acta Neurol Belg; 2021 Apr; 121(2):331-339. PubMed ID: 33464546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does COVID-19 contribute to development of neurological disease?
    Mahalakshmi AM; Ray B; Tuladhar S; Bhat A; Paneyala S; Patteswari D; Sakharkar MK; Hamdan H; Ojcius DM; Bolla SR; Essa MM; Chidambaram SB; Qoronfleh MW
    Immun Inflamm Dis; 2021 Mar; 9(1):48-58. PubMed ID: 33332737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic.
    Dewanjee S; Vallamkondu J; Kalra RS; Puvvada N; Kandimalla R; Reddy PH
    Mol Neurobiol; 2021 Sep; 58(9):4694-4715. PubMed ID: 34169443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nervous system-A new territory being explored of SARS-CoV-2.
    Zhang M; Zhou L; Wang J; Wang K; Wang Y; Pan X; Ma A
    J Clin Neurosci; 2020 Dec; 82(Pt A):87-92. PubMed ID: 33317745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological Involvements of SARS-CoV2 Infection.
    Gasmi A; Tippairote T; Mujawdiya PK; Gasmi Benahmed A; Menzel A; Dadar M; Bjørklund G
    Mol Neurobiol; 2021 Mar; 58(3):944-949. PubMed ID: 33064267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses.
    Hu J; Jolkkonen J; Zhao C
    Neurosci Biobehav Rev; 2020 Dec; 119():184-193. PubMed ID: 33091416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease-(COVID-19).
    Payus AO; Liew Sat Lin C; Mohd Noh M; Jeffree MS; Ali RA
    Bosn J Basic Med Sci; 2020 Aug; 20(3):283-292. PubMed ID: 32530389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological involvement of COVID-19: from neuroinvasion and neuroimmune crosstalk to long-term consequences.
    Septyaningtrias DE; Susilowati R
    Rev Neurosci; 2021 Jun; 32(4):427-442. PubMed ID: 33550780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.
    Montalvan V; Lee J; Bueso T; De Toledo J; Rivas K
    Clin Neurol Neurosurg; 2020 Jul; 194():105921. PubMed ID: 32422545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.
    Román GC; Spencer PS; Reis J; Buguet A; Faris MEA; Katrak SM; Láinez M; Medina MT; Meshram C; Mizusawa H; Öztürk S; Wasay M;
    J Neurol Sci; 2020 Jul; 414():116884. PubMed ID: 32464367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging neurotropic features of SARS-CoV-2.
    Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG
    J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurological manifestations of COVID-19: with emphasis on Iranian patients.
    Aslan C; Nikfarjam S; Asadzadeh M; Jafari R
    J Neurovirol; 2021 Apr; 27(2):217-227. PubMed ID: 33710597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
    Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
    J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological manifestations of coronavirus disease 2019: exploring past to understand present.
    Desai I; Manchanda R; Kumar N; Tiwari A; Kumar M
    Neurol Sci; 2021 Mar; 42(3):773-785. PubMed ID: 33428055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological complications in COVID-19 - a diagnostic challenge.
    Vacaras V; Frunze S; Cordos AM
    J Med Life; 2021; 14(2):216-224. PubMed ID: 34104245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological complications of coronavirus and COVID-19.
    Carod-Artal FJ
    Rev Neurol; 2020 May; 70(9):311-322. PubMed ID: 32329044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does coronaviruses induce neurodegenerative diseases? A systematic review on the neurotropism and neuroinvasion of SARS-CoV-2.
    ElBini Dhouib I
    Drug Discov Ther; 2021 Jan; 14(6):262-272. PubMed ID: 33390561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.